AAP/CDC Pediatric Anthrax Clinical Management

-A   +A

AAP/CDC Pediatric Anthrax Clinical Management


With support from the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP) convened a workshop in November 2012 to develop pediatric anthrax clinical guidance. Workgroups were formed to develop draft content for issues related to antibiotics, vaccine post-exposure prophylaxis, and other treatments. Approximately 50 AAP and federal representatives attended the 2-day workshop, held at the CDC Tom Harkin Global Communications Center in Atlanta, Georgia. The workshop included an anthrax scenario demonstration, reports from the AAP and CDC, workgroup presentations and discussions, a detailed review of a draft guidance document, identification of research needs, and presentations on the unique needs of children, public health response strategies, and the communication needs of health care professionals and families.

The AAP published new recommendations in May 2014. See Pediatric Anthrax Clinical Management and an Executive Summary, as well as a companion AAP News article “Report from AAP, CDC offers guidance on managing children after anthrax attack". The authors would like to acknowledge the members of the AAP/CDC Pediatric Anthrax Guidance Writing Group for their assistance with writing and discussing recommendations.

AAP/CDC Pediatric Anthrax Guidance


  • Laura D. Aird, MS, American Academy of Pediatrics (AAP) Staff
  • Michael R. Anderson, MD, FAAP, Cleveland, OH
  • Michael Bartenfeld, MA, Centers for Disease Control and Prevention (CDC)
  • Dahna Batts, MD, CDC
  • Tina Bhavsar, PharmD, CDC
  • Luciana L. Borio, MD, US Food and Drug Administration (FDA)
  • William A. Bower, MD, FIDSA, CDC
  • John Bradley, MD, FAAP, San Diego, CA
  • Sarita Chung, MD, FAAP, Boston, MA
  • Amanda Cohn, MD, CDC
  • Sean Diederich, AAP Staff
  • Diane Dubinsky, MD, FAAP, Fairfax, VA
  • Daniel Fagbuyi, MD, FAAP, Upper Marlboro, MD
  • Doran L. Fink, MD, PhD, FDA
  • Margaret Fisher, MD, FAAP, Long Branch, NJ
  • Jennifer Frantz, MPH, AAP Staff
  • Richard Gorman, MD, FAAP, National Institutes of Health
  • Susan Gorman, PharmD, MS, DABAT, FAACT, CDC
  • Katherine Hendricks, MD, MPH & TM, CDC
  • Mark Hudak, MD, FAAP, Jacksonville, FL
  • Timothy Johnson, DO, MMM, FAAP, Kansas City, MO
  • Timothy W. Johnson, CDC
  • Cynthia L. Kelley, MS, FDA
  • James King, MD, FAAP, Office of the Assistant Secretary for Preparedness and Response (ASPR)
  • Suzanne Kirkwood, MS, AAP Staff
  • Leonard R. Krilov, MD, FAAP, Mineola, NY
  • Steven E. Krug, MD, FAAP, Chicago, IL
  • Brad Leissa, MD, FDA
  • Edward D. Lewis, MD, FAAP, Rochester, NY
  • Dana Meaney-Delman, MD, MPH, CDC
  • Brenda Mears, MD, FAAP, Dallas, TX
  • Nancy Messonnier, MD, CDC
  • Scott Needle, MD, FAAP, Naples, FL
  • Lori O’Keefe, AAP Consultant
  • Erica Pan, MD, MPH, FAAP, Oakland, CA
  • Sarah Y. Park, MD, FAAP, Honolulu, HI
  • Andrew T. Pavia, MD, FAAP, FIDSA, Salt Lake City, UT
  • Georgina Peacock, MD, MPH, FAAP, CDC
  • Conrad P. Quinn, PhD, CDC
  • Jean Randolph, RN, CDC
  • David Schonfeld, MD, FAAP, Philadelphia, PA
  • Thomas Schrup, MD, FAAP, Saint Cloud, MN
  • David Siegel, MD, FAAP, National Institute for Child Health and Human Development
  • Daniel Sosin, MD, MPH, FACP, CDC
  • Helen Stallings, MSPH, ASPR
  • V. Fan Tait, MD, FAAP, AAP Staff
  • Tracee Treadwell, DVM, MPH, CDC
  • Robert M. Ward, MD, FAAP, FCP, Salt Lake City, UT


            print           email           share